| Application of Epiduo(R) PUMP in Daily Practice in Patients With Inflammatory Acne (NCT02338544) | Galderma Laboratorium GmbH | 2015-01-01 |
| Psychological Factors in Acne: A Focus on Psychological Trauma (NCT02314039) | Edinburgh Napier University | 2015-01-01 |
| Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne (NCT02320149) | Almirall, S.A. | 2014-12-18 |
| Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne (NCT02322866) | Almirall, S.A. | 2014-12-03 |
| P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris (NCT02242760) | Novan, Inc. | 2014-11-01 |
| Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris (NCT02431494) | Nova Southeastern University | 2014-10-30 |
| The Effect of a Low Glycemic Load Diet on Hormonal Markers Associated With Acne (NCT02913001) | New York University | 2014-09-01 |
| A Phase 1 Study Assessing Local Cutaneous Effects of SB204 (NCT02250430) | Novan, Inc. | 2014-09-01 |
| A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris (NCT02249104) | Galderma R&D | 2014-08-01 |
| Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris (NCT02411942) | Sun Pharmaceutical Industries, Inc. | 2014-08-01 |
| Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris (NCT02218034) | Allergan | 2014-08-01 |
| Pharmacokinetic Study of MTC896 Gel in Subjects With Acne (NCT02293018) | Mimetica Pty Limited | 2014-08-01 |
| A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris (NCT02411955) | Sun Pharmaceutical Industries, Inc. | 2014-06-01 |
| A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris (NCT02164084) | Novan, Inc. | 2014-06-01 |
| A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris (NCT02267746) | Actavis Inc. | 2014-06-01 |
| Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris (NCT02160678) | G & W Laboratories Inc. | 2014-05-01 |
| Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris (NCT02100527) | Pfizer | 2014-04-01 |
| Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris (NCT02929719) | Sun Pharmaceutical Industries, Inc. | 2014-04-01 |
| Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris (NCT02066545) | Maruho Co., Ltd. | 2014-04-01 |
| Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris. (NCT02073448) | Galderma R&D | 2014-03-01 |
| A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris (NCT02032407) | Allergan | 2013-12-01 |
| A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris (NCT01974141) | Almirall, S.A. | 2013-11-01 |
| Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris (NCT01974323) | Almirall, S.A. | 2013-11-01 |
| To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel (NCT02005666) | Zydus Lifesciences Limited | 2013-11-01 |
| Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029 (NCT01938482) | GlaxoSmithKline | 2013-10-31 |
| Study to Investigate the Irritation Potential of GSK1940029 Gel (NCT01984801) | GlaxoSmithKline | 2013-10-14 |
| Effect of a Low-glycemic-load and Milk-free Diet on Acne Severity (NCT01969175) | Parc Taulí Hospital Universitari | 2013-10-01 |
| Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris (NCT01880320) | Galderma R&D | 2013-07-01 |
| Efficacy of Handheld Acne Heat Device (NCT01613924) | University of British Columbia | 2013-07-01 |
| Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel (NCT01885910) | Derm Research, PLLC | 2013-07-01 |
| A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition (NCT02498288) | GlaxoSmithKline | 2013-05-31 |
| A Long Term Study of GK530G in Subjects With Acne Vulgaris (NCT01910064) | Galderma R&D | 2013-05-01 |
| Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers (NCT01830764) | Dermira, Inc. | 2013-04-01 |
| A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel (NCT01844739) | Novan, Inc. | 2013-04-01 |
| A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne (NCT01844752) | Novan, Inc. | 2013-04-01 |
| An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris (NCT01831960) | Intrepid Therapeutics, Inc. | 2013-04-01 |
| Is Acne a Skin Disease Affecting the Brain Functions? Neurocognition in Patients With Acne Vulgaris (NCT01931774) | Bezmialem Vakif University | 2013-04-01 |
| A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris (NCT01915732) | GlaxoSmithKline | 2013-04-01 |
| An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris (NCT01785836) | Allergan | 2013-03-01 |
| BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris (NCT01815450) | Braintree Laboratories | 2013-02-01 |
| "Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy" (NCT01694433) | University of California, Los Angeles | 2013-02-01 |
| Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris (NCT01773122) | Allergan | 2013-01-21 |
| Effectiveness and Safety of New Botanical Component-LFCO- Compared With Existing TTO in Clinical Study (NCT01930565) | Seoul National University Hospital | 2013-01-01 |
| Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne (NCT01425320) | Allergan | 2013-01-01 |
| Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris (NCT01769235) | Sun Pharmaceutical Industries, Inc. | 2012-11-01 |
| A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris (NCT01769664) | Sun Pharmaceutical Industries, Inc. | 2012-09-01 |
| Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers (NCT01694810) | Novan, Inc. | 2012-09-01 |
| Safety Study of Plasma Treatment System to Treat Back Acne (NCT01662349) | Moe Medical Devices | 2012-08-01 |
| Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris (NCT01788384) | Watson Laboratories, Inc. | 2012-07-01 |
| Effects of Acleara Needle Insert on Acne (NCT01677221) | Theravant Corporation | 2012-07-01 |
| Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris (NCT01628549) | Almirall, S.A. | 2012-06-30 |
| Dose Range Study of CD5789 in Acne Vulgaris (NCT01616654) | Galderma R&D | 2012-06-20 |
| Long-term Study of Epiduo in Patients With Moderate to Severe Acne (NCT01618773) | Galderma Laboratorium GmbH | 2012-06-01 |
| A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris (NCT01631474) | Intrepid Therapeutics, Inc. | 2012-06-01 |
| Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne (NCT01629797) | Northwestern University | 2012-05-01 |
| Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel (NCT01522456) | Galderma R&D | 2012-04-01 |
| A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne (NCT01584674) | KLOX Technologies Inc. | 2012-03-01 |
| Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris (NCT01474798) | Janssen Research & Development, LLC | 2012-02-29 |
| Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients (NCT01362010) | Vyne Therapeutics Inc. | 2012-01-01 |
| Effect of Samples on Acne Treatment With Epiduo® Gel (NCT01504204) | Wake Forest University | 2011-12-01 |
| Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris (NCT01498874) | XOMA (US) LLC | 2011-12-01 |
| Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris (NCT01461655) | LEO Pharma | 2011-11-01 |
| Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects (NCT01445301) | GlaxoSmithKline | 2011-09-27 |
| Identifying the Genetic Predictors of Severe Acne Vulgaris and the Outcome of Oral Isotretinoin Treatment (NCT01727440) | Duke University | 2011-09-01 |
| A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris (NCT01492647) | Janssen Pharmaceutical K.K. | 2011-08-01 |
| Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin (NCT01387048) | University of Magdeburg | 2011-08-01 |
| A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne (NCT01422785) | Zeichner, Joshua, M.D. | 2011-07-01 |
| Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris (NCT01448733) | Zeichner, Joshua, M.D. | 2011-07-01 |
| Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects (NCT01400932) | GlaxoSmithKline | 2011-07-01 |
| A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris (NCT01501799) | Actavis Mid-Atlantic LLC | 2011-07-01 |
| Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris (NCT02219074) | Sebacia, Inc. | 2011-06-01 |
| A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris (NCT01347879) | Photocure | 2011-05-01 |
| A Study of a New Drug Treatment for Acne (NCT01326780) | Bausch Health Americas, Inc. | 2011-03-31 |
| Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris (NCT01320033) | Galderma R&D | 2011-03-29 |
| Efficacy of Azadirachta Indica (Homoeopathic Medicine) in Treatment of Acne Vulgaris (NCT01321645) | Miglani, Anjali | 2011-03-01 |
| Acne Treatment With Active Oplon's Patches - 15-18 Years Old (NCT01260766) | Oplon-Pure Science Ltd. | 2011-01-01 |
| Clinical Trial To Evaluate ANT-1207 In Subjects With Acne (NCT01293552) | Anterios Inc. | 2011-01-01 |
| A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products (NCT01313728) | Bausch Health Americas, Inc. | 2010-12-01 |
| Japanese Phase 1 Study of GSK2585823 (NCT01428466) | GlaxoSmithKline | 2010-11-18 |
| A Novel Combination Oral Agent to Treat Acne Vulgaris (NCT01301586) | Nexgen Dermatologics, Inc. | 2010-11-01 |
| BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris (NCT01241331) | Braintree Laboratories | 2010-11-01 |
| Assessment of Subjects' Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris (NCT01209949) | Galderma R&D | 2010-10-01 |
| 2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne (NCT01472900) | Chulalongkorn University | 2010-10-01 |
| Comparing OTC Acne Treatment to Prescription Regimen (NCT01237821) | Milton S. Hershey Medical Center | 2010-10-01 |
| Afamelanotide in Patients Suffering With Acne Vulgaris (NCT04943159) | Clinuvel Pharmaceuticals Limited | 2010-08-24 |
| Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients (NCT01160848) | Photocure | 2010-08-01 |
| Acne Treatment With Active Oplon's Patches (NCT01180543) | Oplon-Pure Science Ltd. | 2010-08-01 |
| A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne (NCT01231334) | Allergan | 2010-08-01 |
| Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris (NCT01149330) | Galderma Brasil Ltda. | 2010-07-01 |
| A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers. (NCT01119651) | Stiefel, a GSK Company | 2010-06-14 |
| W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne (NCT01132443) | Stiefel, a GSK Company | 2010-05-06 |
| A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers (NCT01115322) | Stiefel, a GSK Company | 2010-04-01 |
| A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers (NCT01114841) | Stiefel, a GSK Company | 2010-03-31 |
| A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers (NCT01112787) | Stiefel, a GSK Company | 2010-03-26 |
| Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel (NCT01188538) | Galderma R&D | 2010-03-01 |
| Efficacy of Lappa Arctium (Homoeopathic Medicine) in Treatment of Acne Vulgaris (NCT01040390) | Miglani, Anjali | 2010-03-01 |
| Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH) (NCT01038869) | Derm Research, PLLC | 2009-12-01 |
| Reduced Side-Effects of Photodynamic Therapy for the Treatment of Moderate to Severe Acne (i-PDT) (NCT01689935) | Massachusetts General Hospital | 2009-11-01 |
| A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris (NCT01019603) | Stiefel, a GSK Company | 2009-10-12 |
| Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne (NCT01682200) | Medivet Pty Ltd | 2009-10-01 |